© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 85547 refers to a laboratory test that evaluates the mechanical fragility of red blood cells (RBCs). This test is crucial for understanding how susceptible RBCs are to hemolysis, which is the process of rupture or destruction of these cells when they are subjected to various forms of stress. Mechanical fragility testing is particularly challenging to standardize due to the complexities involved in simulating the shear stress that RBCs may encounter in clinical settings. Typically, the procedure involves placing a sample of whole blood into a test tube that contains glass beads. The test tube is then vigorously agitated, which mimics the mechanical forces that RBCs might experience during medical procedures. Following this agitation, the sample is analyzed for hemoglobin levels to assess the degree of damage sustained by the RBCs. This test is especially significant in contexts such as dialysis, intra-operative auto-transfusion, and other medical interventions that utilize devices like pumps, valves, cannulas, or gas exchange systems. Additionally, it is important to note that stored blood products can also undergo mechanical stress, leading to potential damage to the RBCs, making this test relevant for ensuring the quality and safety of transfused blood products.
© Copyright 2025 Coding Ahead. All rights reserved.
The mechanical fragility test of red blood cells (RBCs) is indicated in various clinical scenarios where the integrity of RBCs may be compromised. The following conditions and situations warrant the performance of this test:
The procedure for testing mechanical fragility of red blood cells involves several key steps that ensure accurate assessment of RBC integrity. The following outlines the procedural steps:
Post-procedure care for the mechanical fragility test is generally minimal, as it is a laboratory-based test. However, it is important to monitor the patient for any adverse reactions related to the blood draw, such as bruising or discomfort at the venipuncture site. The results of the test should be communicated to the healthcare provider for further evaluation and management, especially if significant RBC fragility is detected. This information can be critical in guiding treatment decisions, particularly in patients undergoing procedures that may impact RBC integrity.
Short Descr | RBC MECHANICAL FRAGILITY | Medium Descr | MECHANICAL FRAGILITY RBC | Long Descr | Mechanical fragility, RBC | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Date
|
Action
|
Notes
|
---|---|---|
Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.